Triple combination therapy with histamine dihydrochloride, interferon alpha-2B (IFN) and ribavirin for chronic hepatitic C treatment-failures: 48 week results: Yoav Lurie, Stephen Malnick, Ronit Pakula, Mark Beer-Gabel, Kaplan Medical Center, Rehovot Israel; Kurt R Gehlsen, Maxim Pharmaceuticals, San Diego, CA; Avidan U Neumann, Bar Ilan Univ, Ramat Gan Israel

• Book ID: 118689020
• Publisher: John Wiley and Sons
• Year: 2001
• Tongue: English
• Weight: 180 KB
• Volume: 34
• Category: Article
• ISSN: 0270-9139
• DOI: 10.1053/s0270-9139(00)82771-8